All lobbying filings

Bluebird Strategies

Bluebird Strategies filed a Q1 amendment for Thermo Fisher Scientific Inc. on April 6, 2026, reporting $21,000 in lobbying income.

Lobbying for Thermo Fisher Scientific Inc. · Scientific product and technology company.

As filed: BLUEBIRD STRATEGIES for THERMO FISHER SCIENTIFIC INC.

All filings by Bluebird Strategies · Everything Thermo Fisher Scientific Inc. has reported

Filing · LD-2 quarterly report Q1 amendment

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 6, 2026

Income

$21,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Engage Senate and House on proposed legislation to promote the appropriate use of FDA cleared preeclampsia biomarker testing as part of the Medicaid program

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.